Publications 2021

Fossdal G, Mjelle AB, Wiencke K, Bjork I, Gilja OH, Folseraas T, Karlsen TH, Rosenberg W, Giil LM, Vesterhus M (2021)
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
JHEP Rep., 3 (5), 100328
DOI 10.1016/j.jhepr.2021.100328

Publications 2016

Eskeland SL, Brunborg C, Seip B, Wiencke K, Hovde O, Owen T, Skogestad E, Huppertz-Hauss G, Halvorsen FA, Garborg K, Aabakken L, de Lange T (2016)
First quality score for referral letters in gastroenterology - a validation study
BMJ Open, 6 (10), e012835
DOI 10.1136/bmjopen-2016-012835

Publications 2011

Wiencke K, Boberg KM (2011)
Current consensus on the management of primary sclerosing cholangitis
Clin. Res. Hepatol. Gastroenterol., 35 (12), 786-791
DOI 10.1016/j.clinre.2011.04.007

Publications 2007

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broome U, Schreiber S, Boberg KM (2007)
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis
Am. J. Gastroenterol., 102 (1), 115-121
DOI 10.1111/j.1572-0241.2006.00928.x

Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A (2007)
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes
Tissue Antigens, 69 (2), 161-169
DOI 10.1111/j.1399-0039.2006.00738.x

Publications 2006

Wiencke K (2006)
Genetic studies in primary sclerosing cholangitis
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 442, 1 b. (flere pag.)
BIBSYS 061913405

Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A (2006)
No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis
Scand. J. Gastroenterol., 41 (5), 586-591
DOI 10.1080/00365520500377870

Publications 2005

Lorentzen AR, Celius EG, Ekstrom PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF (2005)
Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients
J. Neuroimmunol., 166 (1-2), 197-201
DOI 10.1016/j.jneuroim.2005.06.002

Publications 2004

Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM, IBSEN study grp (2004)
Association of matrix metalloproteinase-1 and-3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients
J. Hepatol., 41 (2), 209-214
DOI 10.1016/j.jhep.2004.04.024

Publications 2003

Bjoro K, Brandsaeter B, Wiencke K, Bjoro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand. J. Gastroenterol., 38 (3), 320-327
DOI 10.1080/00365520310000681

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)3, s.320-7
BIBSYS 041707508

Etokebe GE, Wiencke K, Haug T, Spurkland A (2003)
The use of modified primer competitors to enhance yields and specificity of HLA class I amplification by polymerase chain reaction (PCR)
Tissue Antigens, 61 (2), 172-176
DOI 10.1034/j.1399-0039.2003.00011.x

Publications 2001

Wiencke K, Spurkland A, Schrumpf E, Boberg KM (2001)
Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles
Hepatology, 34 (4), 625-630
DOI 10.1053/jhep.2001.27543

Publications 1988

Wiencke K (1988)
Murin friend erythroleukemi virus infeksjon: en mulig modell for HIV/AIDS?
[K. Wiencke], [Trondheim], 64 s.
BIBSYS 885009770